Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Profound Medical (TSE:PRN)
TSX:PRN
PRN Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$7.90 - C$15.75
Previous CloseN/A
Volume2.80K
Average Volume (3M)5.74K
Market Cap
C$288.87M
Enterprise ValueC$235.77M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.92
Next Earnings
Mar 06, 2025EPS Estimate
-0.46Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.82
Shares Outstanding30,028,477
10 Day Avg. Volume5,851
30 Day Avg. Volume5,737
Standard Deviation0.23
R-Squared0.03
Alpha-0.00030
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)19.25
Price to Cash Flow (P/CF)-6.80
P/FCF Ratio0.00
Enterprise Value/Market Cap0.82
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit53.80
Enterprise Value/Ebitda-7.43
Forecast
1Y Price Target
C$24.12Price Target Upside129.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Profound Medical News
PremiumCompany Announcements
Profound Medical to Announce 2024 Financial Results and Host Conference Call
PremiumCompany Announcements
Profound Medical Reports Robust Revenue Growth and Transition to U.S. GAAP
PremiumCompany Announcements
Profound Medical to Present at J.P. Morgan Healthcare Conference---
Bulls Say, Bears Say
Bulls Say
Market PositioningProfound Medical is well-positioned to tap into the massive prostate cancer and BPH markets with its TULSA technology.
Reimbursement And ProfitabilityFavorable CPT-1 reimbursement codes are expected to make TULSA procedures profitable from the start, driving adoption under Medicare.
Sales And GrowthThe company has fielded a high-caliber sales team, which has positioned the company to generate triple-digit growth in 2026 and beyond.
Bears Say
Equity DilutionThe target price for the stock mechanically reduces to $17.00 due to equity dilution.
Equity IssuanceThe issuance of new shares was at a 7% discount to the previous closing price, but shares were trading above this issue price, indicating investor confidence.
Operational GoalsThe company's goal of 75 TULSA installs by year-end seems unlikely to be achieved.
---
Options Prices
Currently, No data available
---
Ownership Overview
18.59% Insiders
1.49% Mutual Funds
36.16% Other Institutional Investors
43.71% Public Companies and
Individual Investors
PRN FAQ
What was Profound Medical’s price range in the past 12 months?
Profound Medical lowest stock price was C$7.90 and its highest was C$15.75 in the past 12 months.
What is Profound Medical’s market cap?
Profound Medical’s market cap is C$288.87M.
When is Profound Medical’s upcoming earnings report date?
Profound Medical’s upcoming earnings report date is Mar 06, 2025 which is in 13 days.
How were Profound Medical’s earnings last quarter?
Profound Medical released its earnings results on Nov 07, 2024. The company reported -C$0.539 earnings per share for the quarter, missing the consensus estimate of -C$0.426 by -C$0.113.
Is Profound Medical overvalued?
According to Wall Street analysts Profound Medical’s price is currently Undervalued.
Does Profound Medical pay dividends?
Profound Medical does not currently pay dividends.
What is Profound Medical’s EPS estimate?
Profound Medical’s EPS estimate is -0.46.
How many shares outstanding does Profound Medical have?
Profound Medical has 30,028,477 shares outstanding.
What happened to Profound Medical’s price movement after its last earnings report?
Profound Medical reported an EPS of -C$0.539 in its last earnings report, missing expectations of -C$0.426. Following the earnings report the stock price went down -2.996%.
Which hedge fund is a major shareholder of Profound Medical?
Currently, no hedge funds are holding shares in TSE:PRN
---
Profound Medical Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$24.12 (129.50% Upside)
C$24.12 (129.50% Upside)
Blogger Sentiment
Bullish
TSE:PRN Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth C$354.6K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-11.41%
12-Months-Change
Fundamentals
Return on Equity
-90.83%
Trailing 12-Months
Asset Growth
-16.34%
Trailing 12-Months
Company Description
Profound Medical
Profound Medical Corp is a medical technology company. It provides incision-free therapies that combine real-time Magnetic Resonance (MR) imaging, thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue. The company develops a treatment to ablate the prostate gland in prostate cancer patients.
---
PRN Stock 12 Month Forecast
Average Price Target
C$24.12
▲(129.50% Upside)
Technical Analysis
Best Analysts Covering PRN
1 Year
1 Year Success Rate
3/14 ratings generated profit
1 Year Average Return
-10.55%
reiterated a buy rating 8 days ago
Copying Ben Haynor's trades and holding each position for 1 Year would result in 21.43% of your transactions generating a profit, with an average return of -10.55% per trade.
---